Latest Bristol-Myers Squibb Stories
Research findings enable disease molecular sub-typing to lead to more informed clinical decision-making IRVING, Texas, Jan.
RARITAN, N.J., Jan. 16, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today the U.S.
QINGDAO, China and ROCKVILLE, Md., Jan. 14, 2014 /PRNewswire/ -- Synutra International, Inc.
The FDA has approved the use of a new type 2 diabetes drug called Farxiga, developed by pharmaceutical companies Bristol-Meyers Squibb and AstraZeneca.
Pharma Industry Veteran Brings Full-Spectrum Healthcare Expertise to One of Venture Industry's Most Active Life Sciences Investors CHEVY CHASE, Md. and MENLO PARK, Calif., Jan.
Editor Note: For more information about this release, please scroll to bottom. NEW YORK, January 9, 2014 /PRNewswire/ -- Today, Analysts' Corner announced new research
- First approved combination of oral targeted therapies for unresectable or metastatic melanoma with BRAF V600E or V600K mutations LONDON, Jan.
- A young chicken: also used as a pet name for children.